New Results
Targeting primary and metastatic uveal melanoma with a G protein inhibitor
View ORCID ProfileMichael D. Onken, Carol M. Makepeace, Kevin M. Kaltenbronn, Joelle Choi, Leonel Hernandez-Aya, Katherine N. Weilbaecher, Kisha D. Piggott, P. Kumar Rao, Carla M Yuede, Alethia J. Dixon, Patrick Osei-Owusu, John A. Cooper, Kendall J. Blumer
doi: https://doi.org/10.1101/2021.01.16.426957
Michael D. Onken
1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110
Carol M. Makepeace
2Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110
Kevin M. Kaltenbronn
2Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110
Joelle Choi
2Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110
Leonel Hernandez-Aya
3Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110
Katherine N. Weilbaecher
3Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110
Kisha D. Piggott
4Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110
P. Kumar Rao
4Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110
Carla M Yuede
5Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110
Alethia J. Dixon
6Department of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA, 19102
Patrick Osei-Owusu
6Department of Pharmacology & Physiology, Drexel University College of Medicine, Philadelphia, PA, 19102
John A. Cooper
1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110
Kendall J. Blumer
2Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110
Posted January 17, 2021.
Targeting primary and metastatic uveal melanoma with a G protein inhibitor
Michael D. Onken, Carol M. Makepeace, Kevin M. Kaltenbronn, Joelle Choi, Leonel Hernandez-Aya, Katherine N. Weilbaecher, Kisha D. Piggott, P. Kumar Rao, Carla M Yuede, Alethia J. Dixon, Patrick Osei-Owusu, John A. Cooper, Kendall J. Blumer
bioRxiv 2021.01.16.426957; doi: https://doi.org/10.1101/2021.01.16.426957
Targeting primary and metastatic uveal melanoma with a G protein inhibitor
Michael D. Onken, Carol M. Makepeace, Kevin M. Kaltenbronn, Joelle Choi, Leonel Hernandez-Aya, Katherine N. Weilbaecher, Kisha D. Piggott, P. Kumar Rao, Carla M Yuede, Alethia J. Dixon, Patrick Osei-Owusu, John A. Cooper, Kendall J. Blumer
bioRxiv 2021.01.16.426957; doi: https://doi.org/10.1101/2021.01.16.426957
Subject Area
Subject Areas
- Biochemistry (11703)
- Bioengineering (8718)
- Bioinformatics (29127)
- Biophysics (14930)
- Cancer Biology (12048)
- Cell Biology (17353)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14143)
- Epidemiology (2067)
- Evolutionary Biology (18266)
- Genetics (12219)
- Genomics (16765)
- Immunology (11841)
- Microbiology (28003)
- Molecular Biology (11551)
- Neuroscience (60804)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3229)
- Physiology (4939)
- Plant Biology (10383)
- Synthetic Biology (2877)
- Systems Biology (7333)
- Zoology (1642)